Lymphatic Malformation in Adults

A two-stage double-blind, randomized, placebo-controlled study to assess the efficacy, safety of new drug in adult patients with lymphatic malformations associated with a specific gene mutation.

Trial requirements

• Are > 18 years old
• Have a documented diagnosis of a symptomatic lymphatic malformation
• Are in good general health
• Are able to attend our Sydney clinic

There will be other study requirements that the study team will discuss with potential participants. This clinical trial duration is up to 6 months and at least 2 years of monitoring post the conclusion of treatment.
There is no cost to take part in this clinical trial and reasonable travel costs will be reimbursed.

Lymphatic Malformation in Adults - The Skin Hospital
-

Common questions from patients

Questions before joining a clinical trial are common. Our team are here to help.

Actively recruiting

Current clinical trials

View our current and up coming clinical trials.

We would like to acknowledge the Traditional Custodians of the lands on which The Skin Hospital operates. For thousands of years, these lands have been cared for by Indigenous communities and their ancestors. We recognise and appreciate their ongoing connection to Country, culture, and community. We also pay our respects to the elders, past and present, of these communities, as well as to all Aboriginal and Torres Strait Islander peoples who have contributed to the cultural heritage of this country.
flags
© The Skin Hospital 2025
Site by Sod